SARAH EMMERICH: Open Payments
NPI 1497352728 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,905 in 138 payments from 28 companies in 2025. Trend: 2023 $2,466 · 2024 $3,629 · 2025 $2,905
Food & beverage: $2,905
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $404 |
| PFIZER INC. | 17 | $342 |
| AstraZeneca Pharmaceuticals LP | 10 | $298 |
| Novo Nordisk Inc | 17 | $231 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $213 |
| Lilly USA, LLC | 9 | $196 |
| Astellas Pharma US Inc | 6 | $140 |
| Hologic Sales and Service, LLC | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 5 | $117 |
| Aimmune Therapeutics, Inc. | 5 | $112 |
Products named: AIRSUPRA, ELIQUIS, VRAYLAR, Kerendia, MOUNJARO, NURTEC ODT, Veozah, APTIMA.
Industry payments across WI — which companies pay providers there.
